Previous studies have not reported such a remarkable effect of IDO2 on lymph node metastatic status [60], suggesting that IDO2 may play distinct roles based on the pathophysiologic feature or immune microenvironment of different cancers. This evidence concerns the gene IDO2 and cancer.